RARG and cancer: Thus, to our knowledge, the current study is the first to demonstrate—in human PDAC specimens—that RARγ was overexpressed in the nucleus of cancer cells and that the expression of RARγ increased during the progression of PDAC, including PanIN, a precancerous lesion of PDAC.